课程概述
热门审阅
HG
Oct 15, 2018
Very well done and informative. I truly appreciate the Drug process in entirety being broken down into sections that are easy to comprehend. It is obvious the speakers were chosen for their knowledge.
KR
May 24, 2020
I am really glad to have course offered by california university . Its really helpful for me. And i am thankful to all lecturer, and teachers to explain overall drug development process.\n\nThank you!
376 - 药物开发 的 400 个评论（共 400 个）
创建者 Krithika S K N
•Sep 2, 2019
Was informative. The lectures could have been more structured and slides more detailed.
创建者 Adrija C
•Nov 2, 2020
US- centric course. The content in week 3 was not well explained and felt rushed.
创建者 Aneesh T G
•Aug 23, 2020
More emphasis on the filing and submissions and approvals need to be there
创建者 Carolina S V
•Dec 27, 2017
Weeks 1 and 2 are great, but the classes of week 3 need more organization.
创建者 Damien V
•Sep 17, 2018
good up to phase 2 (included). Phase 3 and after was less informative
创建者 Sean K
•Feb 21, 2022
Lot of outdated information and poor presentation slides
创建者 Brian M
•Apr 25, 2021
It's from 2013. Good overview but time for an update.
创建者 Miguel M V
•Aug 31, 2020
would like an specialization on this matter
创建者 Budupula K
•Jun 19, 2021
I gained knowledge
创建者 Sofia B J
•Sep 2, 2020
goooooood
创建者 Aman b
•Sep 15, 2021
good
创建者 DR. A G
•Sep 5, 2020
good
创建者 Pratiksha
•Jun 2, 2020
n
i
c
e
创建者 Dale G Y
•Aug 24, 2021
Had hoped to hear a better description of the types of trials and more about the Regulators' logic in deciding what trials a drug must have - PK for ANDA? BE for ANDA? P1 and P3 for 505B2? Does PK=P1? These topics are useful. Need to define these options and explain the reason for using them for different scenarios. That's part of what I expected from Drug Development.
The lecture style of second half was difficult. More structure, clear pronunciation, less random thoughts about unexplained topics.
创建者 Mohamed T H
•Jul 18, 2020
Phase 1 was explained nicely. But phase 2 description was unclear with some diagrams with not much context and a lot of acronyms thrown around. Did not learn a lot about phase 3 either. The presentation slides were very busy like the previous course.
创建者 Malamati V
•Oct 23, 2020
I felt like the lectures were not so organized as far as their material is concerned. I also found the overall course more "business-oriented" than actually educational.
创建者 Nayanika P
•Jan 8, 2022
Okayish. I wouldn't recommend this. If you're really passionate about Drug Development and it's clinical aspects, try and find better courses.
创建者 Alejandro G
•May 28, 2020
The course was not structured as an online course. the slides were quite boring and some of the speakers were not enthusiastic
创建者 Arash Y
•Mar 3, 2018
Presentation slides and sound quality is at its lowest.
创建者 Maria B
•Mar 18, 2020
The course is not prepared for online course
创建者 Benoit E
•Feb 21, 2019
A lot too much bla bla on the Phase iv part
创建者 Michael M
•Sep 9, 2020
I only looked at the slides, as I wanted to confirm, what I read in some of the reviews. A standard issue on Coursera is, that material is not maintained and updated. I have worked in the pharmaceutical industry for more than 15 years now and everything is constantly evolving. The world of 2013 is not the world of 2020 and course material should e updated regularly.
创建者 Ananya S
•Jul 13, 2020
The data shown in the lecture and even the lecture itself is dated back to 2012. Kindly upload an updated lecture with new rules, recent data, recent examples. It would be of great help.
创建者 19BBT051-SHARVAISH D R B B
•Sep 19, 2020
Nice very important
创建者 Ramani D
•May 24, 2020
Thank u so much
Coursera Footer
